N. Denko

Molecular Biology · 2006–2009

A researcher in the Science corpus: 3 papers; trusts 12 researchers and is trusted by 25 researchers here, as inferred from the citation graph.

Subfields

Whom N. Denko trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. G. Semenza
  2. Jung-whan Kim
  3. M. Höckel
  4. Eyal Gottlieb
  5. Robert A. Gatenby
  6. Amato J. Giaccia
  7. R. Fukuda
  8. W. Dröge
  9. Cheng-Jun Hu
  10. Ralph J. Deberardinis

Who trusts N. Denko overall

  1. Jie Zheng
  2. G. Semenza
  3. Georgina N. Masoud
  4. C. Yun
  5. D. Shackelford
  6. R. Cairns
  7. L. Gray
  8. R. Hamanaka
  9. Y. Zhao
  10. A. Schulze

Papers from N. Denko's perspective

Ordered by how strongly the researchers N. Denko trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation (Science)
  2. Why do cancers have high aerobic glycolysis? (Nature Reviews. Cancer)
  3. Targeting HIF-1 for cancer therapy (Nature Reviews. Cancer)
  4. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. (Cell Metabolism)
  5. Myc Stimulates Nuclearly Encoded Mitochondrial Genes and Mitochondrial Biogenesis (Molecular and Cellular Biology)
  6. HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing (Science)
  7. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. (Cell Metabolism)
  8. ATP citrate lyase inhibition can suppress tumor cell growth. (Cancer Cell)
  9. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. (Journal of the National Cancer Institute)
  10. Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth (PLoS Biology)

Their papers